Opendata, web and dolomites


The role of NLRC4 inflammasome in autoinflammatory diseases

Total Cost €


EC-Contrib. €






 INFLA-AID project word cloud

Explore the words cloud of the INFLA-AID project. It provides you a very rough idea of what is the project "INFLA-AID" about.

inflammation    causes    joined    inhibitors    models    mutations    hyperactivated    promotes    1b    platforms    cytokines    animals    mediated    eliminate    inflammasomopathies    pathogenesis    attributed    manifestation    closely    vigorously    vivo    clinical    restricted    mechanism    regulated    il    mitigate    locate    patients    begins    deficient    provides    host    aetiology    diseases    mutant    aid    onset    unravel    except    protein    hyperactivation    bacterial    toxic    multiprotein    lamkanfi    downstream    vary    amongst    proinflammatory    inflammasomes    pathogenic    caspase    systematic    cell    components    activate    cytokine    microbes    gain    pro    levels    types    patterns    clinicians    flag    innate    activating    data    autoinflammatory    inflammatory    function    disease    array    organs    mouse    symptoms    immune    substances    mutation    limited    infancy    provokes    aberrant    alters    protective    signalling    acumen    breeding    life    infection    inflammasome    threatening    molecular    knock    nlrc4    administered    lab    mice    overproduction    expression    initiates    first   

Project "INFLA-AID" data sheet

The following table provides information about the project.


Organization address
postcode: 9052

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Total cost 172˙800 €
 EC max contribution 172˙800 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-10-01   to  2021-01-29


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VIB VZW BE (ZWIJNAARDE - GENT) coordinator 172˙800.00


 Project objective

'Our immune system provides a protective mechanism to control and eliminate elements from pathogenic microbes and toxic substances. Upon bacterial infection, our innate immune system initiates a pro-inflammatory response by activating the 'inflammasomes'. These multiprotein platforms activate caspase-1 to produce proinflammatory cytokines. An array of highly regulated inflammasome-mediated signalling pathways are identified. When the signalling pathway is hyperactivated, overproduction of the downstream cytokines provokes autoinflammatory diseases (AID). Recently, gain-of-function mutations in the NLRC4 inflammasome have been attributed for the manifestation of NLRC4-associated AID (NLRC4-AID). The clinical symptoms vary in these patients, except that the onset of life-threatening systematic inflammation begins at infancy. What is common amongst the NLRC4-AID patients is their limited response to IL-1b inhibitors typically administered for AID. I have joined the Lamkanfi lab to unravel the aetiology and pathogenesis of the NLRC4-AID. While the NLRC4 inflammasome has been vigorously studied at the molecular level, in vivo data are restricted to knock-out mouse models. Using the NLRC4-Flag knock-in mice, I will analyse in vivo NLRC4 protein levels and expression patterns to locate organs and cell types important for NLRC4-mediated inflammation. Next, NLRC4 mutant mice generated in the host lab will be used to identify how the hyperactivation of NLRC4 alters its signalling pathway and promotes AID. The role of downstream cytokine signalling will be assessed by breeding NLRC4 mutant mice to animals deficient in various immune components, which are available from the host institute. This study will provide first acumen into how an NLRC4 mutation causes an autoinflammatory disease, and will contribute to a better understanding of inflammasomopathies. By working closely with clinicians, we aim to mitigate the symptoms in patients with aberrant NLRC4 inflammasome activities.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INFLA-AID" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INFLA-AID" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

Long-term migration (2019)

Immigration, Attitudes of Natives and Immigrants Assimilation

Read More  


A multilinear approach to the restriction problem with applications to geometric measure theory, the Schrödinger equation and inverse problems

Read More  

NPsVLCD (2019)

Natural Product-Inspired Therapies for Leishmaniasis and Chagas Disease

Read More